Position in EXEL
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$45,801,140
+$9,697,282 QoQ
Shares Held
841,778
0.0% QoQ
Ownership
0.340%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#51
of 751 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swedbank AB holds $1,373,398,390 across 23 Biotechnology names. EXEL ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
10,726,608 | $601,440,910 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
968,092 | $233,281,129 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
282,444 | $140,298,407 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
189,848 | $118,377,821 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,314,787 | $75,232,112 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
841,778 | $45,801,140 | |
| 7 | INCY |
Incyte Corp
|
371,387 | $42,100,430 | |
| 8 | 775,032 | $24,359,255 |
All Filings in EXEL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,801,140 | 841,778 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $36,103,858 | 841,778 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $36,895,129 | 841,778 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $34,765,431 | 841,778 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $37,105,574 | 841,778 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $31,511,057 | 946,278 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $24,555,914 | 946,278 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $21,262,866 | 946,278 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $22,455,176 | 946,278 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,060,979 | 169,278 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $248,609 | 11,378 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $217,433 | 11,378 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $220,846 | 11,378 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $182,503 | 11,378 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $178,407 | 11,378 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $21,921,398 | 1,052,901 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $24,968,239 | 1,101,378 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $20,133,189 | 1,101,378 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $23,283,130 | 1,101,378 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $20,067,107 | 1,101,378 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $24,880,129 | 1,101,378 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||